Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 0 | 692,550 | +692,550 | 0 | 30,403 | 28.54% | +30,403 |
| Hims & Hers Health, Inc.(HIMS) | 3,833,381 | 3,326,783 | -506,598 | 34,117 | 51,465 | 48.31% | +17,348 |
| Disc Medicine, Inc.(IRON) | 243,513 | 243,513 | 0 | 14,065 | 15,161 | 14.23% | +1,096 |
| Kinnate Biopharma Inc. | 3,525,957 | 3,525,957 | 0 | 8,357 | 9,379 | 8.80% | +1,023 |
| 23andMe Holding Co. | 232,200 | 232,200 | 0 | 212 | 124 | 0.12% | -89 |
| Theseus Pharmaceuticals, Inc. | 4,108,796 | 0 | -4,108,796 | 16,641 | 0 | — | -16,641 |